ROVI Pharma Industrial Services

Water for Injection (WFI) sits at the heart of sterile injectable manufacturing, yet it is often underestimated until it becomes a bottleneck. As demand for biologics, vaccines and high-value injectables grows, WFI has evolved from a background utility into a strategic operational decision. This article explores why many pharmaceutical and biotech companies are re-evaluating whether to build or outsource WFI capability, the risks of getting it wrong, and how specialist CDMOs can provide compliant, scalable and lower-risk solutions.

The pharma timeline has compressed — and sponsors are feeling the pressure. High-value injectables require not just capacity but the agility to pivot faster than ever. In this article we unpack the root causes and outline how sponsors can de-risk scale-up through smarter partner selection and earlier regulatory alignment. Practical, realistic and timely.

🌍 As demand for complex injectables continues to accelerate, ROIS is investing in the capacity and capabilities needed to support the next generation of therapies. Our new Phoenix facility strengthens US-based sterile fill-finish operations, adding specialist cytotoxic vial filling and lyophilization capabilities to support ADCs and other complex injectable products 💉🧬 The article explores: ✅ The growing demand for injectables and ADCs 📈 ✅ Expansion of US manufacturing capabilities 🏭 ✅ Advanced fill-finish and lyophilization technologies ⚙️ ✅ Growing partnerships across the global pharma industry 🤝 Read more below ➡️ https://lnkd.in/gT9aZNSh #ROIS #CDMO #Injectables #ADC #Lyophilization #FillFinish #SterileManufacturing #PharmaManufacturing #Biotech

🚀 ROIS is entering a new phase of global growth 🌍 With the acquisition of a commercial injectable manufacturing facility in Phoenix, Arizona 🇺🇸, ROIS is strengthening its position as a leading global CDMO for sterile injectables 💉 The expansion adds significant US-based sterile fill-finish capacity, including specialist cytotoxic lyophilization manufacturing capabilities, ADCs aseptic filling and complex injectable therapies 🧬 The article explores: ✅ The market growth for Injectables and ADC's 🌐 ✅ Expansion of US manufacturing capabilities 🏭 ✅ Advanced fill-finish technologies ⚙️ ✅ Growing partnerships across the global pharma industry 🤝 Read more below ➡️ https://lnkd.in/gT9aZNSh #ROIS #CDMO #Injectables #FillFinish #SterileManufacturing #ADC #Cytotoxic